Cancer treatment Bali usually means Indonesian patients flying out to Singapore or Jakarta. The Sanur Health Special Economic Zone (SEZ) is trying to change that by building an oncology and nuclear medicine hub in South Bali – but as of mid‑2026, much of this ecosystem is still under construction or in commissioning.
What “cancer treatment in Bali” actually covers
In this article, “cancer treatment Bali” refers to three broad components of care:
- Diagnosis – imaging (CT, MRI, PET‑CT), biopsy, pathology, staging.
- Active treatment – surgery, radiotherapy, systemic therapies (chemotherapy, targeted therapy, immunotherapy), nuclear medicine therapies.
- Supportive and survivorship care – pain and symptom management, rehab, psycho‑oncology, palliative and hospice support.
Historically, Bali has offered decent diagnostic imaging and surgery for common solid tumours, but has depended heavily on Java or overseas centres for advanced radiotherapy, comprehensive medical oncology and nuclear medicine. The Sanur SEZ – with Bali International Hospital as the anchor – is designed to plug those gaps by pairing a private tertiary hospital with international ecosystem partners.
All facts and timelines below are based on Indonesian government regulations and public operator statements available up to June 2026. Patients should treat every service description as indicative only and confirm directly with providers before making decisions. This page is not medical advice.
Why cancer drives outbound medical travel from Indonesia
The outbound pattern: Singapore, Malaysia, Japan
Multiple Indonesian government and industry reports over the last decade converge on the same pattern:
- Indonesia loses large numbers of oncology patients to Singapore, Malaysia and beyond each year, primarily from Jakarta, Surabaya and Medan, with Bali as a secondary contributor.
- Cancer is consistently listed among the top two or three reasons for outbound medical travel, alongside cardiac and advanced diagnostics.
- Typical destinations for Indonesian oncology patients:
- Singapore – for integrated cancer centres and clinical trials.
- Penang and Kuala Lumpur – for more price‑sensitive radiotherapy and chemotherapy.
- Japan, South Korea and increasingly Australia – for specific advanced protocols or second opinions.
The government’s rationale for designating the Sanur area in Denpasar as a Health Special Economic Zone is explicitly to capture part of this outbound flow, including oncology.
Key reasons patients leave Bali and Indonesia for cancer care
Historically, cancer patients from Bali have left the island for four main reasons:
- Limited radiotherapy and nuclear medicine capacity in Bali.
Traditional radiotherapy and nuclear medicine facilities have been concentrated in Java. Bali residents diagnosed with cancer often travel to Surabaya, Jakarta or Yogyakarta for a full course of treatment that may last weeks to months, or they go overseas if they can afford it. - Fragmented care pathways.
Patients widely report having to manage separate queues and referrals across imaging, surgery, chemotherapy and palliative care, often in different cities. By contrast, leading regional centres offer “one‑roof” cancer centres with coordinated teams. - Perceived quality and technology gap.
The perception – sometimes accurate, sometimes not – is that neighbouring countries have newer radiotherapy machines, more sub‑specialised oncologists and wider access to targeted and immunotherapy drugs. - Confidentiality and comfort.
Higher‑income patients sometimes choose Singapore or Malaysia for privacy and a more anonymous experience, especially for high‑profile or sensitive cases.
The Sanur SEZ, and particularly Bali International Hospital, has been framed by policymakers as a response to those gaps. The success of the strategy will depend on what actually operates on the ground and how consistently it performs.
Sanur Health SEZ: what is planned for oncology and nuclear medicine
The Sanur Health SEZ (Kawasan Ekonomi Khusus Kesehatan Sanur) is a defined zone in South Denpasar that integrates:
- Bali International Hospital (BIH) – a new private tertiary hospital built by the state‑owned InJourney and its subsidiaries.
- Support facilities – hotels, residences for medical and wellness tourists, and a retirement‑living component.
- Health‑supporting infrastructure – expanded utilities, road access and (in theory) streamlined licensing and customs for medical technology and pharmaceuticals.
Oncology & nuclear medicine in the SEZ blueprint
In public presentations and government filings up to June 2026, oncology is repeatedly listed as a key service line for Bali International Hospital. Official materials describe planned capabilities that include:
- Medical oncology – systemic cancer treatment (chemotherapy and newer systemic drugs).
- Surgical oncology – complex tumour surgery.
- Radiation oncology – external beam radiotherapy.
- Nuclear medicine – for both diagnostics (such as PET‑CT) and select therapies.
A critical detail for any serious reader: much of this is still “planned” or “in development” language. Public documentation has not yet provided a line‑by‑line, unit‑by‑unit operational start list for all specific machines (for example, individual linear accelerators or PET‑CT scanners) or the full specialist roster. Announcements are strategy; commissioning is reality.
Icon Group as ecosystem partner – single‑source and still emerging
One of the most important names in the Sanur oncology story so far is Icon Group, an Australian‑founded cancer care network.
Indonesia’s Ministry of State‑Owned Enterprises and InJourney have publicly presented Icon Group as an international ecosystem partner for oncology and nuclear medicine across the state‑led hospital portfolio, including Bali International Hospital.
What this probably entails (based on Icon’s global model and public Indonesian‑language statements):
- Design input for oncology departments (layout, patient flow, radiation safety).
- Support for establishing radiotherapy, chemotherapy day units and, in some markets, nuclear medicine.
- Clinical protocols and training collaborations.
However:
- The concrete, operational scope of Icon Group’s day‑to‑day role inside Bali International Hospital is not fully documented in public, English‑language, regulation‑grade sources as of June 2026.
- Details such as the exact number of radiotherapy machines, their models, nuclear medicine therapy capabilities and full local consultant roster have not yet been published in a stable regulatory filing.
This means any statement that “Icon operates X machines in Sanur” or that a specific radiotherapy or nuclear medicine service is live today would be speculation. KEK Sanur Intelligence will only update that level of detail once we can link it to a dated, verifiable primary source.
What cancer services are realistically available in Bali now?
Baseline: pre‑SEZ oncology Bali
Before the Sanur SEZ, Bali residents generally accessed cancer care through:
- Provincial public hospitals and select private hospitals in Denpasar and nearby areas, offering:
- Surgery for many solid tumours.
- Conventional imaging – ultrasound, CT, MRI.
- Chemotherapy services, largely for common regimens.
- Radiotherapy and more advanced oncology in Java (Jakarta, Surabaya, Yogyakarta) or overseas.
- Private clinics offering second opinions and post‑treatment follow‑up.
Nuclear medicine in Bali has historically been very limited, particularly for advanced diagnostics such as PET‑CT and for radionuclide therapies. Patients requiring these services have generally travelled off‑island.
Bali International Hospital: oncology positioning
Bali International Hospital, as the anchor of the Sanur SEZ, is being marketed as a tertiary‑level facility intended to:
- Handle complex diagnoses and treatment for both Indonesian and foreign patients.
- Integrate oncology with cardiology, neurology and other major specialties.
- Leverage the SEZ regime to import specialised drugs and equipment more efficiently.
However, the oncology offering – especially radiation oncology and nuclear medicine – is in a ramp‑up phase. As of mid‑2026:
- We have high‑level confirmation that oncology is a core service line.
- We do not yet have a fully transparent, public list of:
- All oncology sub‑specialties in daily operation.
- The exact status of radiotherapy units (accepted, commissioned, treating patients?).
- Which nuclear medicine modalities (if any) are already scanning or treating patients.
Patients should treat any marketing promise of “full oncology services already running” with caution and request specific, dated confirmations from the hospital’s patient liaison or international department.
How nuclear medicine fits into the Bali story
“Nuclear medicine Bali” means two families of services:
- Diagnostic: PET‑CT, SPECT‑CT, bone scans, thyroid and cardiac nuclear imaging.
- Therapeutic: radioiodine for thyroid disease, radionuclide therapies for certain cancers (for example, some neuroendocrine tumours, prostate cancer in select protocols).
In Indonesia, nuclear medicine is tightly regulated, with additional licensing for radiation safety, radioactive material handling and waste disposal. The SEZ is expected to make it easier to import isotopes and equipment, but it does not remove the core radiation‑safety rules.
As of June 2026, there is:
- Clear high‑level intent to develop nuclear medicine in the Sanur area.
- Insufficient publicly verified detail to say which nuclear medicine modalities have already treated patients in the SEZ.
Again, for nuclear medicine specifically, patients must verify:
- Is the modality (for example, PET‑CT, radioiodine therapy) licensed and live?
- What days and times are radioactive tracers available?
- If cross‑border isotopes are required, how reliable is supply?
Why the Sanur SEZ matters for oncology Bali patients
Even in its early stages, the Sanur SEZ shifts the economics and logistics for cancer patients in several ways.
1. On‑island access for Bali residents
For Bali residents, having a tertiary hospital and, in time, a comprehensive cancer centre on the island can mean:
- Fewer flights to Java or overseas just to receive standard chemoradiation.
- Less disruption to work, family and caregiving arrangements.
- Potentially shorter waiting times for certain diagnostics and procedures once capacity fully ramps up.
However, this will vary strongly by tumour type and stage. Highly specialised protocols and clinical trials may still require travel to Jakarta, Singapore or beyond.
2. A structured path for international patients
For international patients considering “cancer care Sanur” as part of broader wellness, retirement or digital‑nomad plans, the SEZ structure is intended to provide:
- Clearer regulatory status for foreign patients receiving intensive treatment in Indonesia.
- Co‑located accommodation and long‑stay facilities appropriate for multi‑week treatment courses.
- Potential for integrated rehabilitation and wellness services alongside conventional oncology – for example, physiotherapy, mental‑health support and nutrition within the same precinct.
For any foreign patient, immigration status, insurance coverage and continuity with home‑country oncologists remain critical planning issues.
3. Synergies with retirement and long‑stay health tourism
Sanur has long catered to retirees and long‑stay visitors. The SEZ formalises this by integrating:
- A health‑focused precinct – with hospital, clinics and supporting services.
- Accommodation options that can be adapted for reduced‑mobility or post‑surgery needs.
- Planned wellness and rehabilitation facilities.
For older residents or retirees in Bali, this raises a realistic question: if cancer is diagnosed during a long stay, will on‑island treatment be viable, or will evacuation still be required? In the early years of SEZ operation, that answer will differ case by case, depending on the specific tumour and required modalities.
Mid‑treatment relocation between countries is logistically and emotionally hard. Any retiree or long‑stay expatriate should discuss contingency plans with both local providers and their home‑country health system or insurer.
If you are trying to map out a realistic care pathway and local vs. overseas options, you can plan your trip with our research team; we can also coordinate detailed question lists for you to raise over WhatsApp with hospitals and clinics.
Cost transparency: what cancer care in Sanur might cost
No official, comprehensive cancer price list for Bali International Hospital or other Sanur SEZ facilities is publicly posted as of June 2026. Any specific number quoted without date and source should be treated skeptically.
That said, we can outline relative cost positions based on historic Indonesian private‑hospital pricing, government references for DRG/INA‑CBG tariffs and widely reported regional benchmarks.
Indicative oncology cost ranges (private sector, Indonesia vs region)
All ranges below are indicative for private care and are not specific quotes from Bali International Hospital. They aggregate common patterns observed in major Indonesian cities and regional medical hubs. “Last verified” refers to when these comparative ranges were last cross‑checked against publicly available references and market interviews.
| Service | Indonesia (private, major cities) Indicative range, last verified June 2026 |
Singapore (private) Indicative range, last verified June 2026 |
Notes |
|---|---|---|---|
| Initial specialist oncology consult | ~IDR 700,000 – 1,800,000 | ~IDR 2,000,000 – 4,500,000 (SGD equiv.) | Follow‑up visits often lower. |
| CT scan with contrast | ~IDR 2,500,000 – 6,000,000 | ~IDR 6,000,000 – 12,000,000 | Price varies by body part and contrast use. |
| MRI (single region) | ~IDR 3,500,000 – 8,500,000 | ~IDR 8,000,000 – 16,000,000 | Premium for sedation or specialised protocols. |
| Standard chemotherapy cycle (common regimens, day case) | ~IDR 8,000,000 – 40,000,000 | Often >IDR 35,000,000 per cycle | Drug choice is the main cost driver. |
| Targeted / immunotherapy infusion (per cycle) | ~IDR 25,000,000 – >150,000,000 | Often higher than Indonesia for same molecule | Highly dependent on molecule and dosing. |
| Radiotherapy course (conventional, curative intent) | ~IDR 35,000,000 – 120,000,000 | Commonly >IDR 120,000,000 | Includes planning and ~20–30 fractions. |
| PET‑CT scan | ~IDR 15,000,000 – 35,000,000 (in cities that offer it) | ~IDR 25,000,000 – 50,000,000 | Tracer availability and import cost matter. |
| Major cancer surgery (e.g. colorectal resection, mastectomy with node dissection) | ~IDR 60,000,000 – 200,000,000 | Often >IDR 200,000,000 | Length of stay and ICU use drive the upper range. |
Key points for Sanur:
- As a premium private facility in a SEZ, Bali International Hospital is likely to sit in the upper half of Indonesian private‑hospital price ranges for comparable oncology services once fully operational.
- Even at the upper end, total episode costs may still undercut equivalent care in Singapore or Australia in many scenarios, especially for self‑pay patients.
- Drug prices, especially for patented targeted therapies and immunotherapies, may cluster closer to regional benchmarks because they depend on global supply chains and IP regimes.
Patients should always ask for:
- Itemised estimates for each phase – diagnostics, surgery, radiotherapy, systemic therapy.
- Clear separation between professional fees, hospital facility charges, drug costs and disposables.
- Written policies on deposit, refunds and changes in plan if staging or pathology results alter the treatment approach.
How to plan a cancer care pathway using Sanur SEZ
1. Clarify the status of SEZ services for your cancer type
For each major tumour type (breast, colorectal, lung, prostate, gynaecologic, haematologic malignancies and so on), ask the Sanur providers directly:
- Which parts of my pathway can you manage on‑island right now (diagnosis, surgery, chemo, radiation, nuclear medicine)?
- Which parts would you refer to another Indonesian centre or overseas partner?
- Is there a documented protocol or tumour board process in place?
If answers are vague – “we can handle all cancers” without specifics – request a call or video consult with a named oncologist to discuss the realities for your case.
2. Align timelines with visas and accommodation
Common oncology timelines:
- Diagnostic work‑up: 1–3 weeks (imaging, biopsy, pathology, staging).
- Standard chemoradiation course: 5–8 weeks (daily or near‑daily visits for radiotherapy, plus weekly chemotherapy in many regimens).
- Post‑operative recovery before flying: 7–21 days depending on surgery.
For international patients using Sanur:
- Check which visa class best matches your expected stay and the SEZ’s regulations.
- Confirm whether you must remain within the SEZ precinct for certain services or benefits.
- Budget for potential extensions if treatment changes mid‑course.
3. Coordinate with your home oncologist or GP
A strong cancer pathway generally involves:
- Pre‑travel discussion with your home‑country doctor, including:
- Which parts of treatment are safe to do abroad.
- How to handle complications or adverse events.
- Documented transfer of medical records (reports, imaging, pathology slides if needed).
- Agreement on who leads follow‑up once you return home.
Some insurers or national systems may require pre‑approval before you receive cancer care overseas. Confirm this upfront to avoid reimbursement shocks.
4. Build in non‑medical support
Cancer treatment is not only about machines and drugs. In Sanur, consider:
- Access to psycho‑oncology or counselling (in Indonesian and, where needed, in English).
- Accommodation suitable for immunocompromised patients (clean air, hygiene, minimal crowding).
- Proximity to emergency care in case of sudden complications.
If you want structured help mapping these non‑medical logistics alongside potential treatment options, you can plan your trip with our team; we can help you prepare precise information requests and provider checklists to work through via WhatsApp with hospitals and clinics.
Risks, limitations and what to watch
Do not assume: verify everything directly
Marketing narratives for new medical hubs are often ahead of operational reality. For cancer care Sanur, verify:
- That the advertised service (for example, IMRT radiotherapy, PET‑CT, a specific immunotherapy) has actually been delivered to patients on‑site, not just installed or announced.
- Which professional teams are permanently based in Bali versus flying in periodically.
- What backup plans exist if a key machine goes down or an imported tracer or drug shipment is delayed.
Regulatory and quality questions to ask
Patients or their advocates should ask:
- Which Indonesian licences and accreditations the hospital holds, and their expiry dates.
- Whether any international accreditations (for example, hospital‑level quality frameworks) are in place or in process, and for which departments.
- How often multidisciplinary tumour boards meet, and which specialties participate.
- How radiotherapy and nuclear medicine doses are verified and audited.
Financial protection limits
Self‑pay international patients are especially vulnerable to cost overruns. Clarify:
- Whether estimates for a “course” of treatment include pre‑treatment tests, management of complications and post‑treatment imaging.
- What happens if a pathology re‑review changes your diagnosis mid‑way.
- How currency fluctuations might affect quoted ranges if you are paying in foreign currency.
Who is Sanur SEZ oncology particularly suitable for?
Subject to confirmation of live services, the Sanur SEZ is most likely to suit:
- Bali‑based and nearby Indonesian patients who want to avoid repeated flights to Java or abroad for standard diagnostics, surgery and systemic therapy, and who value proximity to family.
- Indonesia‑based expatriates and long‑stay visitors seeking an English‑capable environment and easier coordination with international insurers, while staying within Indonesia.
- Retirees and long‑stay residents in Sanur who want an on‑island anchor for basic to intermediate oncology needs, recognising that some advanced or rare cases will still require referral.
It may be less suitable as of mid‑2026 for:
- Patients requiring niche therapies available only in limited global centres or clinical trials.
- Those whose home‑country systems provide full coverage only if treatment is received domestically.
- People who highly prioritise being close to a pre‑existing family support network in another city or country.
Is it safe to wait for Sanur instead of going to Java or overseas?
For some early‑stage cancers, a delay of a few weeks might be clinically acceptable; for others, it is not. That assessment can only be made by qualified oncologists who know your case. Regulatory and economic analysis – including this page – cannot substitute for that.
If a provider suggests “waiting a few months until a new machine opens,” insist on a written opinion from an oncologist addressing the medical safety of that delay.
Frequently asked questions about cancer treatment in Bali’s Sanur SEZ
Is full oncology care already available at Bali International Hospital?
As of June 2026, oncology is a declared key service line at Bali International Hospital, but detailed, publicly verifiable information on which specific oncology, radiotherapy and nuclear medicine services are fully live is limited. Treat any “everything is already operational” statement as marketing unless the hospital can provide dated confirmations for the exact services you need.
Can I get radiotherapy and nuclear medicine treatment in Sanur now?
There is clear intent to provide radiotherapy and nuclear medicine within the Sanur Health SEZ, with Icon Group named as an ecosystem partner. However, hard public data on which modalities are already treating patients is not available as of June 2026. You must confirm directly with the hospital’s oncology or international patient team and ask specifically about licensing, commissioning status and recent patient volumes.
Is cancer treatment in Bali cheaper than in Singapore or Australia?
In most scenarios, Indonesian private‑hospital costs for surgery, chemotherapy and radiotherapy sit below typical Singapore and Australia private prices, and Bali International Hospital is likely to follow that pattern while positioning at the higher end of Indonesian ranges. Drug‑intensive regimens with patented medicines may narrow the gap. Always compare itemised, dated estimates from each option rather than relying on general assumptions.
Can foreign patients use international insurance for cancer care in Sanur?
Some international insurers cover treatment in Indonesian private hospitals; others restrict oncology benefits to certain countries or designated partners. Coverage is policy‑specific. Before committing to Sanur, contact your insurer, provide the full hospital name, and request written confirmation of what is covered, any sub‑limits, and requirements for pre‑authorisation or second opinions.
How do I start planning a cancer care trip to the Sanur Health SEZ?
First, get a clear diagnosis, staging and written summary from your current oncologist. Second, approach Sanur‑based providers with this documentation and request a preliminary treatment outline, estimated costs and an honest statement of what they can and cannot handle locally. For structured support in organising these steps and in compiling precise questions to send via WhatsApp to hospitals, you can plan your trip with KEK Sanur Intelligence’s research team.